Cell And Gene Therapy Catapult
Other professional, scientific and technical activities n.e.c. · London
ActiveUnited KingdomIncorporated 2016Private, Limited by guarantee, no share capital, use of 'Limited' exemption
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
Accounts to 2025-02-28
IXBRL · 24 source facts · 4 selected values
Validation findingsXBRL valid
Accounts to 2025-02-28
IXBRL · 24 source facts · 4 selected values
Validation findings
XBRL valid
- Reporting period
- 2024-03-01 to 2025-02-28
- Extraction status
- complete
- Numeric facts
- 4
- Documents processed
- 1
- XBRL standards validation
- valid
- Filing-profile validation
- invalid
- Parser
- arelle 2.44.4
- Taxonomy
- FRS-102-2023-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_2512_10016023_20250228
- Source archive
- Accounts_Monthly_Data-December2025.zip
Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.
Registered details
10016023- Status
- Active
- Type
- Private, Limited by guarantee, no share capital, use of 'Limited' exemption
- Incorporated
- 2016-02-19
- Jurisdiction
- —
- Registered office
- 12TH FLOOR TOWER WING, GUY'S HOSPITAL, LONDON, SE1 9RT, UNITED KINGDOM
Classification
2 SIC codes7490986900
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
0 SH01-derived roundsNo reconstructed allotment rounds.
Research and innovation
29 matched grantsMRC Centre of Research Excellence in Therapeutic GenomicsActiveMRC · Research and Innovation · 2025-01-01 – 2031-12-31 · with 8 other participants£22,359,397whole project
MRC Centre of Research Excellence in Therapeutic GenomicsActive
MRC · Research and Innovation · 2025-01-01 – 2031-12-31 · with 8 other participants
£22,359,397
whole project
University Of OxfordleadBexorg IncCell And Gene Therapy CatapultDanaher (USA)EveryONE MedicineGenomics EnglandIntellia Therapeutics IncLa Jolla Cancer Research FoundationThe Jackson Laboratory
EDI Hub+: Sharing and Implementing EDI Practices for Sustained Transformation in EPMSActiveEPSRC · Research Grant · 2024-11-01 – 2028-11-01 · with 22 other participants£2,126,624whole project
EDI Hub+: Sharing and Implementing EDI Practices for Sustained Transformation in EPMSActive
EPSRC · Research Grant · 2024-11-01 – 2028-11-01 · with 22 other participants
£2,126,624
whole project
University of Leedslead52 North Health LimitedAberystwyth UniversityAssociation of Research Managers and AdministratorsAston UniversityBee Solutions and Consultancy ServicesBritish Plastics FederationCell & Gene Therapy CatapultDePuy SynthesEngineering Professors CouncilHeriot-Watt UniversityInstitute of PhysicsMott MacDonaldNational Physical LaboratoryNational STEM Learning CentreRail Safety and Standards Board (United Kingdom)Space Skills AllianceUK Health Security AgencyUniversity of BradfordUniversity Of BristolUniversity Of East AngliaUniversity Of YorkWhite Rose University Consortium
Pluripotent stem cell derived hepatocytes for liver failure (PUSH for LIFE)MRC · Research and Innovation · 2024-05-31 – 2025-05-30 · with 1 other participant£245,877whole project
Pluripotent stem cell derived hepatocytes for liver failure (PUSH for LIFE)
MRC · Research and Innovation · 2024-05-31 – 2025-05-30 · with 1 other participant
£245,877
whole project
Imperial College LondonleadCell And Gene Therapy Catapult
Cellular Genomics (CELLGEN): Consequences of somatic genome variation on traitsActiveBBSRC · Institute Project · 2023-03-31 – 2028-03-30 · with 18 other participants£2,121,644whole project
Cellular Genomics (CELLGEN): Consequences of somatic genome variation on traitsActive
BBSRC · Institute Project · 2023-03-31 – 2028-03-30 · with 18 other participants
£2,121,644
whole project
Earlham InstituteleadAstraZenecaAutonomous University of MadridCell And Gene Therapy CatapultCentre for Process Innovation (CPI)James Cook UniversityJohannes Gutenberg University of MainzKing'S College LondonMedical Research Council (MRC)Norfolk And Norwich University HospitalSpanish National Research Council (CSIC)Technical University of DarmstadtTropic Biosciences LtdUniversity Of AberdeenUniversity Of East AngliaUniversity of ManchesterUniversity Of SussexUppsala UniversityWellcome Sanger Institute
Engineering synthetic adhesion receptors to enhance the sensitivity of therapeutic chimeric antigen receptorsMRC · Research Grant · 2022-08-31 – 2025-08-30 · with 1 other participant£482,675whole project
Engineering synthetic adhesion receptors to enhance the sensitivity of therapeutic chimeric antigen receptors
MRC · Research Grant · 2022-08-31 – 2025-08-30 · with 1 other participant
£482,675
whole project
University Of OxfordleadCell And Gene Therapy Catapult
Innovation Launchpad NetworkActiveEPSRC · Research Grant · 2022-04-12 – 2026-08-30 · with 8 other participants£4,880,914whole project
Innovation Launchpad NetworkActive
EPSRC · Research Grant · 2022-04-12 – 2026-08-30 · with 8 other participants
£4,880,914
whole project
University of SheffieldleadCell And Gene Therapy CatapultCompound Semiconductor Applications CatapultDigital CatapultEnergy Systems Catapult LtdHigh Value Manufacturing CatapultMedicines Discovery CatapultOffshore Renewable Energy CatapultSatellite Applications Catapult
Miniaturisation of high throughput healthcare bioreactors for advanced therapeuticsUKRI FLF · Fellowship · 2021-09-30 – 2025-09-29 · with 15 other participants£1,499,910whole project
Miniaturisation of high throughput healthcare bioreactors for advanced therapeutics
UKRI FLF · Fellowship · 2021-09-30 – 2025-09-29 · with 15 other participants
£1,499,910
whole project
Microfluidx LtdleadAminoAcids.comAnthony NolanAstrazenecaAutolusBiopharm ServicesCell And Gene Therapy CatapultColorado Center for Reproductive MedicineImperial College LondonRoyal Free HospitalRoyal Free London NHS Foundation TrustStemmattersUniversity College LondonUniversity of HertfordshireUniversity Of OxfordVTT Technical Research Centre of Finland Ltd
Gene Therapy Innovation and Manufacturing Centre (GTIMC)ActiveMRC · Research Grant · 2021-08-01 – 2026-07-31 · with 18 other participants£6,840,242whole project
Gene Therapy Innovation and Manufacturing Centre (GTIMC)Active
MRC · Research Grant · 2021-08-01 – 2026-07-31 · with 18 other participants
£6,840,242
whole project
University of SheffieldleadAdvanced Manufacturing Research CentreBirmingham Women’s & Children’s NHS Foundation TrustCardiff UniversityCell And Gene Therapy CatapultCell Therapy CatapultCobra BiologicsLeeds Teaching Hospitals NHS TrustLonza AGMedicines & Healthcare pdts Reg Acy MHRAMidland-Wales Advanced Therapy TreatmentNational Horizons CentreNorthern Health Science Alliance LtdSheffield Teaching Hospitals NHS Foundation TrustUniversity College LondonUniversity of BradfordUniversity of CambridgeUniversity Of LeicesterUniversity Of York
NHSBT Innovation Hub for Gene TherapiesActiveMRC · Research Grant · 2021-07-31 – 2026-07-30 · with 2 other participants£4,717,199whole project
NHSBT Innovation Hub for Gene TherapiesActive
MRC · Research Grant · 2021-07-31 – 2026-07-30 · with 2 other participants
£4,717,199
whole project
Patent-reported outcomes assessment to support accelerated access to advanced cell and gene therapies: PROmicsInnovate UK · Centres · 2021-04-01 – 2022-03-31 · with 3 other participants£13,887awarded
Patent-reported outcomes assessment to support accelerated access to advanced cell and gene therapies: PROmics
Innovate UK · Centres · 2021-04-01 – 2022-03-31 · with 3 other participants
£13,887
awarded
Cell And Gene Therapy Catapult£13,887
The Christie NHS Foundation Trust£12,000
University Hospitals Birmingham NHS Foundation Trustlead£9,979
ATTC CoordinationLead
Innovate UK · Collaborative R&D · 2021-04-01 – 2022-03-31
£302,929
awarded
Patent-reported outcomes assessment to support accelerated access to advanced cell and gene therapies: PROmicsISCF · Centres · 2021-03-31 – 2022-03-30 · with 3 other participants£172,840whole project
Patent-reported outcomes assessment to support accelerated access to advanced cell and gene therapies: PROmics
ISCF · Centres · 2021-03-31 – 2022-03-30 · with 3 other participants
£172,840
whole project
University Hospitals Birmingham NHS Foundation TrustleadCell And Gene Therapy CatapultThe Christie NHS Foundation TrustUniversity Of Birmingham
ATTC Coordination
ISCF · Collaborative R&D · 2021-03-31 – 2022-03-30
£302,929
whole project
ATTC CoordinationLead
ISCF · Collaborative R&D · 2021-03-31 – 2022-03-30
£302,929
whole project
Cell therapy for Huntington's disease: addressing critical knowledge gapsActiveMRC · Research Grant · 2021-01-01 – 2026-12-31 · with 4 other participants£2,085,455whole project
Cell therapy for Huntington's disease: addressing critical knowledge gapsActive
MRC · Research Grant · 2021-01-01 – 2026-12-31 · with 4 other participants
£2,085,455
whole project
Cardiff UniversityleadCell And Gene Therapy CatapultEuropean Huntington's Disease Network (Euro-HD)University of BarcelonaUniversity Of Edinburgh
Developing the Caf1 polymer technology into a commercial propositionEP/T005963/1BBSRC · Research Grant · 2020-09-30 – 2022-09-29 · with 4 other participants£190,398whole project
Developing the Caf1 polymer technology into a commercial propositionEP/T005963/1
BBSRC · Research Grant · 2020-09-30 – 2022-09-29 · with 4 other participants
£190,398
whole project
Newcastle UniversityleadCell And Gene Therapy CatapultCell Therapy CatapultLaboratory for Vascular Translational Science (LVTS)University of Cambridge
JPND - Multicellular organoids: modeling, mechanisms and therapy development for C9ORF72-associated neurodegeneration.MRC · Research Grant · 2020-09-30 – 2024-02-29 · with 4 other participants£431,507whole project
JPND - Multicellular organoids: modeling, mechanisms and therapy development for C9ORF72-associated neurodegeneration.
MRC · Research Grant · 2020-09-30 – 2024-02-29 · with 4 other participants
£431,507
whole project
University of SheffieldleadCell And Gene Therapy CatapultJPND ResearchQuell TherapeuticsUniversity of Cambridge
Optimising islet transplantation therapy by targeting the liver niche to promote the long-term engraftment and function of human islets.MRC · Research Grant · 2019-09-29 – 2023-01-31 · with 4 other participants£242,469whole project
Optimising islet transplantation therapy by targeting the liver niche to promote the long-term engraftment and function of human islets.
MRC · Research Grant · 2019-09-29 – 2023-01-31 · with 4 other participants
£242,469
whole project
University Of EdinburghleadCell And Gene Therapy CatapultUK Regenerative Medicine PlatformUniversity Of NottinghamUniversity of Strathclyde
Vascular constructs using human pluripotent stem cells in the therapy of peripheral arterial diseaseMRC · Research Grant · 2018-10-07 – 2021-02-07 · with 3 other participants£344,915whole project
Vascular constructs using human pluripotent stem cells in the therapy of peripheral arterial disease
MRC · Research Grant · 2018-10-07 – 2021-02-07 · with 3 other participants
£344,915
whole project
Imperial College LondonleadAstrazenecaCell And Gene Therapy CatapultNHS Blood And Transplant (Nhsbt)
ISCF Funding for Advanced Therapy Manufacturing ApprenticeshipsLead
Innovate UK · Centres · 2018-07-01 – 2021-04-30
£1,499,198
awarded
ATTC CoordinationLead
Innovate UK · Centres · 2018-06-01 – 2022-03-31
£1,706,975
awarded
ISCF Funding for Phase 2 of the C> Catapult Manufacturing CentreLeadInnovate UK · Centres · 2017-08-01 – 2019-10-31 · with 1 other participant£10,000,000awarded
ISCF Funding for Phase 2 of the C> Catapult Manufacturing CentreLead
Innovate UK · Centres · 2017-08-01 – 2019-10-31 · with 1 other participant
£10,000,000
awarded
Cell Therapy Catapult Ltdlead£10,000,000
Advance On Grant For Catapult Projects£2,000,000
Future Targeted Healthcare Manufacturing HubEPSRC · Research Grant · 2017-01-01 – 2024-12-31 · with 90 other participants£10,851,089whole project
Future Targeted Healthcare Manufacturing Hub
EPSRC · Research Grant · 2017-01-01 – 2024-12-31 · with 90 other participants
£10,851,089
whole project
University College Londonlead3MAdaptimmuneAglaris LtdAlbumedix LtdAlbumedix LtdAllerganAllergan Limited (UK)Applikon Biotechnology B.V.Association of the British Pharmaceutical IndustryAssoc of the British Pharm Ind (ABPI)AstrazenecaAstraZenecaAutolusAutolus LimitedAutolus LtdBIA SeparationsBioindustry AssociationBioLogicB LLCBioLogicB, LLCBiopharm ServicesBiopharm Services LimitedCancer Research UKCell And Gene Therapy CatapultCell Medica Ltd.Celltech Group plcCell Therapy CatapultCentre for Process InnovationCentre for Process Innovation (CPI)CSL BehringdeltaDOT LtdEli Lilly & Company LtdEli Lilly S.A. - Irish BranchFloDesign SonicsFrancis BiopharmaFrancis Biopharma LtdFujifilmFujifilm UK LtdGlaxoSmithKline (GSK)GskImperial College LondonIpsenIrvine ScientificKnowledge Transfer NetworkKnowledge Transfer Network LimitedKuopio Center for Gene and Cell TherapyLaboratory of the Government Chemist (LGC) LtdLgcLgc LtdLonza Biologics PLCLonza GroupMedicines & Healthcare pdts Reg Acy MHRAMedicines Manufacturing Ind PartnershipMedicines Manufacturing Industry PartnershipMerck KGaAMerck Sharpe and DohmeNational Institute for Biological Standards and Control (NIBSC)Novo Nordisk A/SOrchard TherapeuticsOvizio Imaging Systems NV SAOxford BioMedica UK LtdOxford BioMedica (United Kingdom)Pall EuropePerceptive Engineering LimitedPerceptive Engineering LtdPfizerPharmaronPuridifyPuridify LTDPurolite International LtdRedbud LabsReneuronReneuron LtdRepligenRoche Diagnostics GmbHSartoriusSartorius Stedim UK LimitedShanghai Pulmonary HospitalSsc BioSutro BiopharmaTillingbourne Consulting LimitedTrakCelUcb SAUK BioIndustry Association (BIA)United Kingdom Research and InnovationUnivercells LtdUniversity College LondonUniversity of WarwickWest Pharmaceutical ServicesWyatt Technology CorporationWyatt Technology UK Ltd
Manufacturing automation within the supply chain to ensure patient safetyEPSRC · Research Grant · 2016-02-01 – 2017-04-29 · with 1 other participant£125,265whole project
Manufacturing automation within the supply chain to ensure patient safety
EPSRC · Research Grant · 2016-02-01 – 2017-04-29 · with 1 other participant
£125,265
whole project
Cranfield UniversityleadCell And Gene Therapy Catapult
Manufacture of complex protein polymers for industry and medicineBBSRC · Research Grant · 2015-04-30 – 2021-07-30 · with 4 other participants£1,880,175whole project
Manufacture of complex protein polymers for industry and medicine
BBSRC · Research Grant · 2015-04-30 – 2021-07-30 · with 4 other participants
£1,880,175
whole project
Newcastle UniversityleadCell And Gene Therapy CatapultCell Therapy CatapultLaboratory for Vascular Translational Science (LVTS)University of Cambridge
MICA: Development of Metrics and Quality Standards for Scale up of Human Pluripotent Stem CellsMRC · Research Grant · 2015-04-30 – 2017-09-29 · with 5 other participants£1,289,418whole project
MICA: Development of Metrics and Quality Standards for Scale up of Human Pluripotent Stem Cells
MRC · Research Grant · 2015-04-30 – 2017-09-29 · with 5 other participants
£1,289,418
whole project
University Of ManchesterleadCell And Gene Therapy CatapultMedicines Discovery CatapultRandox LaboratoriesTokyo Electron and FBRI KobeTokyo Electron Europe Limited
MICA: Clinical development of erythrocyte encapsulated thymidine phosphorylase - a therapy for mitochondrial neurogastrointestinal encephalomyopathyMRC · Research Grant · 2014-08-19 – 2020-12-19 · with 16 other participants£3,152,197whole project
MICA: Clinical development of erythrocyte encapsulated thymidine phosphorylase - a therapy for mitochondrial neurogastrointestinal encephalomyopathy
MRC · Research Grant · 2014-08-19 – 2020-12-19 · with 16 other participants
£3,152,197
whole project
St George'S University Of LondonleadAzienda Ospedaliera Spedali Civili di BresciaCell And Gene Therapy CatapultEge UniversityIntegrated University Hospital VeronaNeovii BiotechNewcastle UniversityRenaClinicalSt George's HospitalUniversity College LondonUniversity Hospital of MontpellierUniversity of BolognaUniversity of BonnUniversity of LisbonUniversity of VeronaVall d' Hebron Research InstituteWestern Galilee Medical Centre in Nahariya
EPSRC Fellowships in Manufacturing - Regenerative Medicine Manufacture: A Systems Based Research PlatformEPSRC · Fellowship · 2013-08-04 – 2017-08-30 · with 7 other participants£887,758whole project
EPSRC Fellowships in Manufacturing - Regenerative Medicine Manufacture: A Systems Based Research Platform
EPSRC · Fellowship · 2013-08-04 – 2017-08-30 · with 7 other participants
£887,758
whole project
Loughborough Universitylead3DynamicsCell And Gene Therapy CatapultLaboratory of the Government Chemist (LGC) LtdMedicines And Healthcare Regulatory AgencyNational Institute for Biological Standards and Control (NIBSC)University of ExeterUniversity Of Sussex
Expandable Clinical Grade Feeder Cells for hESc DerivationBBSRC · Research Grant · 2012-03-31 – 2014-06-29 · with 2 other participants£142,036whole project
Expandable Clinical Grade Feeder Cells for hESc Derivation
BBSRC · Research Grant · 2012-03-31 – 2014-06-29 · with 2 other participants
£142,036
whole project